Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
NCT05635149
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Adenocarcinoma
Interventions
RADIATION:
radiotherapy
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology